Histological heterogeneity of Ewing’s sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support
- 17 October 2009
- journal article
- Published by Springer Nature in Virchows Archiv
- Vol. 455 (5) , 397-411
Abstract
Ewing’s sarcoma (ES)/peripheral neuroectodermal tumor (PNET) are malignant neoplasms affecting children and young adults. We performed a study to typify the histological diversity and evaluate antibodies that may offer diagnostic/prognostic support. In total, 415 cases of genetically confirmed paraffin-embedded ES/PNET were analyzed on whole sections and in tissue microarrays. This study confirms the structural heterogeneity of ES/PNET, distinguishing three major subtypes: conventional ES (280 cases); PNET (53 cases); and atypical ES/PNET (80), including large cells, vascular-like patterns, spindle pattern, and adamantinoma-like configuration. All cases presented positivity for at least three of the four tested antibodies (CD99, FLI1, HNK1, and CAV1). CAV1 appeared as a diagnostic immunomarker of ES/PNET being positive in CD99-negative cases. Hence, the immunohistochemical analysis confirmed the diagnostic value of all four antibodies, which together cover more than 99% of the tumors, independently of the histological variety. The univariate analysis for survival revealed atypical ES as the only histological parameter apparently associated with less favorable clinical outcome, particularly in the subgroup of patients treated with surgery. In conclusion, the diagnosis of atypical ES is a challenge for the pathologist and needs support from molecular techniques to perform an optimal differential diagnosis with other small round cell tumors.Keywords
This publication has 94 references indexed in Scilit:
- Molecular Diagnosis of Ewing Sarcoma Family of TumorsDiagnostic Molecular Pathology, 2009
- The genetic and evolutionary balances in human NK cell receptor diversitySeminars in Immunology, 2008
- Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinomaBritish Journal of Cancer, 2008
- Caveolin-1 Reduces Osteosarcoma Metastases by Inhibiting c-Src Activity and Met SignalingCancer Research, 2007
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001
- Neoadjuvant Chemotherapy for Ewing's Sarcoma of Bone in Patients Older than Thirty-nine Years: Experience of Twenty-three Cases at the Istituto Ortopedico RizzoliActa Oncologica, 2000
- Reduction of Caveolin 1 Gene Expression in Lung Carcinoma Cell LinesBiochemical and Biophysical Research Communications, 1999
- Detection of EWS/FLI‐1 by Immunostaining. An Adjunctive Tool in Diagnosis of Ewing′s Sarcoma and Primitive Neuroectodermal Tumour on Cytological Samples and Paraffin‐Embedded Archival MaterialSarcoma, 1999
- Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis?European Journal of Cancer, 1995
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958